logo

For the Inventor, By the Inventor

Toyonaka, Japan

Masayasu Kojima

This inventor holds 10 USPTO granted patents. Top assignees: Kurume University, Hasayuki Matsuo, Kenji Kangawa. Active years: 1994-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masayasu Kojima. Retrieved from https://idiyas.com/inventor/masayasu-kojima-xapfobkv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 60.0

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 47(Granted Patents)


Location History:

  • Miyazaki, JP (1994)
  • Miyazaki-ken, JP (1999)
  • Fukuoka, JP (2017)
  • Toyonaka, JP (2008 - 2018)
  • Kurume, JP (2011 - 2021)

Company Filing History:

goldMedal2 out of 33 
 
Kurume University
 patents
silverMedal1 out of 1 
 
Hasayuki Matsuo
 patent
bronzeMedal1 out of 2 
 
Kenji Kangawa
 patents
4. 1 out of 51 
 
National Cerebral and Cardiovascular Center
 patents
5. 1 out of 439 
 
Suntory Limited
 patents
6. 1 out of 1,226 
 
Takeda Pharmaceutical Company Limited
 patents
7. 5 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1994-2024

Loading Chart...
10 patents (USPTO):Explore Patents
1. 12108746 - Transgenic animal having CREBBP gene into which mutation has been introduced (2024-10-08),
2. 11154592 - Method of treating Rett Syndrome (RTT) with ghrelin (2021-10-26),
3. 9938332 - Modified ghrelin peptides (2018-04-10),
4. 9573986 - Modified ghrelin peptides (2017-02-21),
5. 8524871 - Modified gherlin peptides (2013-09-03),
6. 8227570 - Modified gherlin peptides (2012-07-24),
7. 7943580 - Polypeptide and the use thereof (2011-05-17),
8. 7385026 - Modified ghrelin polypeptides (2008-06-10),
9. 5973134 - Rat CNP complementary DNA and precursor protein (1999-10-26),
10. 5360727 - C-terminal .alpha.-amidating enzyme and process for production thereof (1994-11-01),

Title: Masayasu Kojima: Innovator in Genetic Research

Introduction

Masayasu Kojima is a prominent inventor based in Toyonaka, Japan. He has made significant contributions to the field of genetic research, holding a total of 10 patents. His work primarily focuses on transgenic animals and methods for treating genetic disorders.

Latest Patents

Kojima's latest patents include a groundbreaking invention involving a transgenic animal that has had a mutation introduced into its CREBBP gene. This non-human transgenic animal possesses at least one CREBBP gene locus with a mutation that encodes a mutant CREBBP, which has an amino acid sequence exhibiting at least 90% identity with a specified sequence. This invention also outlines a method for producing such transgenic animals, which can serve as models for studying Rubinstein-Taybi syndrome and advanced sleep phase syndrome. Additionally, he has developed a method for treating Rett Syndrome (RTT) through the administration of ghrelin to affected subjects.

Career Highlights

Throughout his career, Kojima has worked with various institutions, including Kurume University. His research has significantly advanced the understanding of genetic disorders and potential treatments.

Collaborations

Kojima has collaborated with notable colleagues such as Hisayuki Matsuo and Kenji Kangawa, contributing to the advancement of genetic research.

Conclusion

Masayasu Kojima's innovative work in genetic research and his numerous patents highlight his dedication to improving the understanding and treatment of genetic disorders. His contributions continue to impact the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…